SundrugLtd Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

SundrugLtd wird ein jährliches Gewinn- und Umsatzwachstum von 5.7% bzw. 5.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 5.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12% betragen.

Wichtige Informationen

5.6%

Wachstumsrate der Gewinne

5.7%

EPS-Wachstumsrate

Consumer Retailing Gewinnwachstum	9.9%
Wachstumsrate der Einnahmen	5.9%
Zukünftige Eigenkapitalrendite	11.9%
Analystenabdeckung	Good
Zuletzt aktualisiert	28 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Analyst Estimates: Here's What Brokers Think Of Sundrug Co.,Ltd. (TSE:9989) After Its Yearly Report

Jun 28

Recent updates

Analyst Estimates: Here's What Brokers Think Of Sundrug Co.,Ltd. (TSE:9989) After Its Yearly Report

Jun 28

Gewinn- und Umsatzwachstumsprognosen

TSE:9989 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (JPY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	915,141	35,401	13,425	64,231	6
3/31/2026	858,929	32,817	12,607	58,926	8
3/31/2025	805,119	30,606	5,533	56,010	8
3/31/2024	751,777	29,126	2,963	41,188	N/A
12/31/2023	736,881	28,120	N/A	N/A	N/A
9/30/2023	722,946	27,035	3,214	39,384	N/A
6/30/2023	706,153	26,305	N/A	N/A	N/A
3/31/2023	690,462	25,703	11,267	37,380	N/A
12/31/2022	676,628	25,213	N/A	N/A	N/A
9/30/2022	661,203	24,120	13,765	36,288	N/A
6/30/2022	650,992	23,350	N/A	N/A	N/A
3/31/2022	648,734	23,853	11,893	31,682	N/A
12/31/2021	645,191	23,608	N/A	N/A	N/A
9/30/2021	644,605	24,306	11,991	29,741	N/A
6/30/2021	641,667	25,079	N/A	N/A	N/A
3/31/2021	634,310	25,329	15,286	31,761	N/A
12/31/2020	634,169	25,423	N/A	N/A	N/A
9/30/2020	617,407	23,638	15,436	29,156	N/A
6/30/2020	622,197	24,200	N/A	N/A	N/A
3/31/2020	617,769	23,692	20,971	32,274	N/A
12/31/2019	607,565	24,564	N/A	N/A	N/A
9/30/2019	612,185	25,742	27,536	37,134	N/A
6/30/2019	594,960	24,342	N/A	N/A	N/A
3/31/2019	588,069	23,933	19,897	31,091	N/A
12/31/2018	583,085	24,288	N/A	N/A	N/A
9/30/2018	578,241	24,554	19,999	32,112	N/A
6/30/2018	571,724	24,948	N/A	N/A	N/A
3/31/2018	564,215	24,829	23,687	36,148	N/A
12/31/2017	555,031	24,590	N/A	N/A	N/A
9/30/2017	546,370	24,155	N/A	35,375	N/A
6/30/2017	536,737	23,684	N/A	N/A	N/A
3/31/2017	528,394	23,312	N/A	28,226	N/A
12/31/2016	524,155	22,684	N/A	N/A	N/A
9/30/2016	517,289	22,216	N/A	29,932	N/A
6/30/2016	511,786	22,207	N/A	N/A	N/A
3/31/2016	503,773	21,569	N/A	33,575	N/A
12/31/2015	492,036	20,881	N/A	N/A	N/A
9/30/2015	480,933	19,971	N/A	28,955	N/A
6/30/2015	466,704	18,056	N/A	N/A	N/A
3/31/2015	445,818	16,362	N/A	12,829	N/A
12/31/2014	449,548	15,122	N/A	N/A	N/A
9/30/2014	442,504	14,389	N/A	22,131	N/A
6/30/2014	440,575	15,167	N/A	N/A	N/A
3/31/2014	447,819	15,754	N/A	32,321	N/A
12/31/2013	431,272	16,335	N/A	N/A	N/A
9/30/2013	425,005	16,001	N/A	23,286	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 9989Das prognostizierte Gewinnwachstum (5.7% pro Jahr) liegt über der Sparquote (0.2%).

Ertrag vs. Markt: 9989Die Erträge des Unternehmens (5.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt JP (8.9% pro Jahr).

Hohe Wachstumserträge: 9989Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 9989Die Einnahmen des Unternehmens (5.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt JP (4.1% pro Jahr).

Hohe Wachstumseinnahmen: 9989Die Einnahmen des Unternehmens (5.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 9989Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12%).

SundrugLtd Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Analyst Estimates: Here's What Brokers Think Of Sundrug Co.,Ltd. (TSE:9989) After Its Yearly Report

Recent updates

Analyst Estimates: Here's What Brokers Think Of Sundrug Co.,Ltd. (TSE:9989) After Its Yearly Report

Full year 2024 earnings: EPS exceeds analyst expectations

SundrugLtd (TSE:9989) Ticks All The Boxes When It Comes To Earnings Growth

Sundrug Co.,Ltd. to Report Q1, 2025 Results on Aug 14, 2024

Full year 2024 earnings: EPS exceeds analyst expectations

Sundrug Co.,Ltd., Annual General Meeting, Jun 21, 2024

Sundrug Co.,Ltd.'s (TSE:9989) Share Price Not Quite Adding Up

Be Wary Of SundrugLtd (TSE:9989) And Its Returns On Capital

Now 21% overvalued after recent price rise

Upcoming dividend of JP¥57.00 per share

SundrugLtd (TSE:9989) Will Pay A Dividend Of ¥57.00

Now 20% overvalued after recent price rise

Sundrug Co.,Ltd. to Report Fiscal Year 2024 Results on May 15, 2024

Third quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Sundrug Co.,Ltd. to Report Q3, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of JP¥57.00 per share at 2.7% yield

Sundrug Co.,Ltd. to Report Q2, 2024 Results on Nov 14, 2023

First quarter 2024 earnings released: EPS: JP¥59.01 (vs JP¥53.86 in 1Q 2023)

Sundrug Co.,Ltd. to Report Q1, 2024 Results on Aug 10, 2023

Sundrug Co.,Ltd., Annual General Meeting, Jun 23, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Upcoming dividend of JP¥50.00 per share at 2.8% yield

Third quarter 2023 earnings released: EPS: JP¥65.36 (vs JP¥56.01 in 3Q 2022)

Sundrug Co.,Ltd. to Report Q3, 2023 Results on Feb 14, 2023

No independent directors

Upcoming dividend of JP¥50.00 per share

Sundrug Co.,Ltd. (TSE:9989) agreed to acquire Daiya, K.K. from Shintaro Ito, Ichiban Co., Ltd and others.

Sundrug Co.,Ltd. to Report Q2, 2023 Results on Nov 14, 2022

First quarter 2023 earnings released: EPS: JP¥53.86 (vs JP¥58.18 in 1Q 2022)

Sundrug Co.,Ltd. to Report Q1, 2023 Results on Aug 12, 2022

Full year 2022 earnings: EPS misses analyst expectations

Sundrug Co.,Ltd., Annual General Meeting, Jun 25, 2022

No independent directors

Sundrug Co.,Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥35.00 per share

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Second quarter 2022 earnings released: EPS JP¥48.36 (vs JP¥54.98 in 2Q 2021)

Upcoming dividend of JP¥35.00 per share

First quarter 2022 earnings released: EPS JP¥58.18 (vs JP¥60.32 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥217 (vs JP¥203 in FY 2020)

Upcoming dividend of JP¥35.00 per share

Sundrug Co.,Ltd. to Report Fiscal Year 2021 Results on May 14, 2021

New 90-day low: JP¥4,020

Third quarter 2021 earnings released: EPS JP¥61.99 (vs JP¥46.72 in 3Q 2020)

Revenue and earnings miss expectations

New 90-day high: JP¥4,515

Sundrug Co.,Ltd. to Report Q3, 2021 Results on Feb 10, 2021

Sundrug Co.,Ltd. to Report Q2, 2021 Results on Nov 11, 2020

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken